tirzepatide weight loss injections thousand oaks GLP-1 Ventura CA CALIFORNIA TRIM CLINIC - Updated

Tirzepatide (trade name Mounjaro) is a new glucose-lowering medicine in the incretin family which, to date, has included the glucagon-like peptide-1 (GLP-1) receptor agonists (such as dulaglutide and semaglutide) and dipeptidyl peptidase-4 (DPP-4) inhibitors (including linagliptin and sitagliptin)

Omega-3 supplements at high doses (typically above 3g daily) may increase bleeding risk, particularly in individuals taking anticoagulants (such as warfarin) or antiplatelet agents (such as aspirin or clopidogrel)

If nausea is severe, persistent, or prevents you from eating or drinking, seek urgent medical advice

In other words, at the end of 88 weeks, those who continued taking tirzepetide had lost on average 60 pounds, and those who went on the placebo maintained a 22-pound weight loss

This is often more about the rapid weight loss that can occur rather than the drug itself